Key Insights
The European pharmaceutical packaging market, valued at approximately €[Estimate based on market size XX and currency conversion, e.g., €15 Billion] in 2025, is projected to experience robust growth, driven by a 7.30% CAGR from 2025 to 2033. This expansion is fueled by several key factors. The rising prevalence of chronic diseases across Europe necessitates increased pharmaceutical production and, consequently, a higher demand for packaging solutions. Stringent regulatory requirements regarding drug safety and efficacy are pushing manufacturers to adopt advanced packaging technologies, such as tamper-evident closures and child-resistant containers. Furthermore, the increasing adoption of innovative drug delivery systems, including injectables and inhalers, is driving demand for specialized packaging formats. The market is segmented by material type (plastic, glass, paper/paperboard, and metal), product type (bottles, vials, ampoules, pouches, syringes, medication tubes, caps and closures, labels, and others), and country (United Kingdom, Germany, France, Spain, Italy, and the Rest of Europe). Germany, France, and the UK are major contributors to the market's growth due to their established pharmaceutical industries and robust healthcare infrastructure.
Competition within the European pharmaceutical packaging market is intense, with both large multinational corporations like Aptargroup Inc., Schott AG, and Gerresheimer AG, and specialized regional players vying for market share. The market presents opportunities for companies offering sustainable and eco-friendly packaging solutions, catering to the growing environmental awareness among consumers and pharmaceutical companies. However, challenges remain, including fluctuations in raw material prices, stringent regulatory compliance, and the increasing need for advanced security features to combat counterfeiting. The forecast period will see ongoing consolidation within the industry, as companies strive to enhance their offerings and expand their geographical reach to capitalize on the market's potential. Future growth will depend on technological advancements, regulatory changes, and the overall health of the European pharmaceutical sector.

Europe Pharmaceutical Packaging Industry: A Comprehensive Market Report (2019-2033)
This insightful report provides a comprehensive analysis of the Europe pharmaceutical packaging market, offering a detailed overview of its current state, future trajectory, and key players. The study period spans from 2019 to 2033, with 2025 serving as both the base and estimated year. The report meticulously examines market trends, technological advancements, and competitive dynamics, equipping stakeholders with actionable intelligence for strategic decision-making. The market is projected to reach xx Million by 2033, demonstrating significant growth potential.
Europe Pharmaceutical Packaging Industry Market Composition & Trends
This section delves into the intricate composition of the European pharmaceutical packaging market, encompassing market concentration, innovation drivers, regulatory frameworks, substitute products, end-user profiles, and M&A activities. The market is moderately consolidated, with several key players holding significant market share. However, the landscape is dynamic, with ongoing innovation and strategic acquisitions shaping market dynamics.
Market Share Distribution (2024 Estimates):
- Top 5 Players: xx% (Combined)
- Remaining Players: xx%
Key Innovation Catalysts:
- Growing demand for sustainable packaging solutions.
- Advancements in barrier technologies to enhance product shelf life.
- Development of smart packaging incorporating track-and-trace capabilities.
Regulatory Landscape:
- Stringent regulations concerning material safety and product traceability.
- Increasing emphasis on environmental sustainability and waste reduction.
Mergers & Acquisitions (M&A) Activity: Recent years have witnessed considerable M&A activity, with deal values exceeding xx Million in aggregate. These transactions reflect strategic consolidation and expansion efforts within the sector. For example, IntraPac International Corporation's acquisition of Precision Concepts Costa Rica in August 2021 significantly expanded their manufacturing capabilities.

Europe Pharmaceutical Packaging Industry Industry Evolution
This section analyses the evolutionary trajectory of the European pharmaceutical packaging industry, tracing its growth patterns, technological progress, and evolving consumer preferences from 2019 to 2033. The market exhibits a steady growth rate, driven by factors such as increasing pharmaceutical production, expanding healthcare infrastructure, and a growing demand for innovative packaging solutions.
The industry is witnessing a shift toward sustainable and innovative materials, reflecting growing environmental concerns and the need for enhanced product protection. The adoption of advanced technologies such as serialization and track-and-trace systems is accelerating, driven by regulatory mandates and the need for improved supply chain transparency. Consumer demand is shifting towards convenience and ease of use, influencing the design and functionality of pharmaceutical packaging. The compound annual growth rate (CAGR) for the forecast period (2025-2033) is estimated at xx%.
Leading Regions, Countries, or Segments in Europe Pharmaceutical Packaging Industry
This section identifies the dominant regions, countries, and segments within the European pharmaceutical packaging market. The analysis considers various parameters, including market size, growth rate, and key drivers.
By Material Type:
- Plastic: Remains the leading material segment, driven by its cost-effectiveness, versatility, and ease of processing. Key drivers include advancements in barrier technologies and the growing demand for lightweight packaging.
- Glass: Maintains a significant market share, particularly for sensitive pharmaceuticals requiring high-barrier properties. Demand is driven by its inertness and suitability for sterilization.
- Others (Paper, Paperboard, Metal): This segment exhibits steady growth driven by increasing demand for eco-friendly and cost-effective solutions.
By Product Type:
- Bottles, Vials, and Ampoules: Dominates the market due to its widespread use in storing and dispensing liquid and injectable pharmaceuticals.
- Syringes: Strong growth is fueled by the increasing demand for injectable drugs and the growing adoption of pre-filled syringes.
- Caps and Closures: A significant segment due to the critical role of these components in ensuring product integrity and safety.
By Country:
- Germany, United Kingdom, and France: These countries represent the largest markets in Europe, driven by established pharmaceutical industries, robust healthcare infrastructure, and high per capita drug consumption.
Key Drivers:
- Significant investments in pharmaceutical manufacturing infrastructure.
- Favorable regulatory environment supporting innovation.
- Growing demand for advanced packaging solutions.
Europe Pharmaceutical Packaging Industry Product Innovations
Recent product innovations include Gerresheimer's Gx Innosafe syringe with passive needle protection, offering enhanced safety and ease of use. The focus is on incorporating advanced features like tamper-evident seals, improved barrier properties, and smart packaging functionalities. These innovations are aimed at improving patient safety, enhancing product shelf life, and streamlining logistics.
Propelling Factors for Europe Pharmaceutical Packaging Industry Growth
Growth is primarily driven by factors like rising pharmaceutical production, an aging population, the increasing prevalence of chronic diseases, regulatory mandates favoring advanced packaging, and substantial investments in research and development. The demand for convenient and child-resistant packaging is also boosting market growth.
Obstacles in the Europe Pharmaceutical Packaging Industry Market
Challenges include stringent regulatory compliance requirements, volatile raw material prices, fluctuating exchange rates, and potential supply chain disruptions. The intense competition among established players and the entry of new market participants are also constraints. These factors collectively contribute to increased production costs and price pressure.
Future Opportunities in Europe Pharmaceutical Packaging Industry
Emerging opportunities lie in developing sustainable and eco-friendly packaging solutions, incorporating advanced features such as smart packaging and drug delivery systems, expanding into emerging markets, and focusing on niche applications like personalized medicine packaging. The increased demand for customized packaging solutions for specialized pharmaceuticals presents significant future growth opportunities.
Major Players in the Europe Pharmaceutical Packaging Industry Ecosystem
- Aptargroup Inc
- SGD Pharma
- Vetter Pharma Packaging
- Schott AG
- Nolato AB
- Ardagh Group SA
- Gaplast GmbH
- Nipro Corporation
- Intrapac Group
- Origin Pharma Packaging
- CCL Industries Inc
- APG Europe
- Piramal Glass Ltd
- Gerresheimer AG
Key Developments in Europe Pharmaceutical Packaging Industry Industry
- August 2021: IntraPac International Corporation acquired Precision Concepts Costa Rica, enhancing its manufacturing capabilities.
- August 2021: Schott AG and Serum Institute of India formed a joint venture for pharmaceutical packaging, securing Serum's supply chain.
- November 2021: Gerresheimer launched Gx Innosafe, an innovative syringe with a passive needle protection system.
Strategic Europe Pharmaceutical Packaging Industry Market Forecast
The European pharmaceutical packaging market is poised for robust growth, driven by factors including technological advancements, increasing demand for innovative packaging solutions, and favorable regulatory environments. Future opportunities abound in sustainable packaging, smart packaging, and specialized drug delivery systems. The market is projected to experience a significant expansion in the coming years, creating lucrative prospects for established and emerging players alike.
Europe Pharmaceutical Packaging Industry Segmentation
-
1. Material Type
- 1.1. Plastic
- 1.2. Glass
- 1.3. Others Materials (Paper and Paperboard And Metal)
-
2. Product Type
- 2.1. Bottles
- 2.2. Vials and Ampoules
- 2.3. Pouches
- 2.4. Syringes
- 2.5. Medication Tubes
- 2.6. Caps and Closures
- 2.7. Labels
- 2.8. Others Product Types
Europe Pharmaceutical Packaging Industry Segmentation By Geography
-
1. Europe
- 1.1. United Kingdom
- 1.2. Germany
- 1.3. France
- 1.4. Italy
- 1.5. Spain
- 1.6. Netherlands
- 1.7. Belgium
- 1.8. Sweden
- 1.9. Norway
- 1.10. Poland
- 1.11. Denmark

Europe Pharmaceutical Packaging Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 7.30% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Growth in Pharmaceutical industries in Emerging economies; Growing demand for drug delivery devices & Blister packaging market; Contribution of Nano-technology in the growth of Europe Pharmaceutical packaging; Growth in over-the-counter market; Developing interest in sustainable packaging materials
- 3.2.2 and integration of smart technologies
- 3.3. Market Restrains
- 3.3.1 Increaing Packaging costs; Stricter health regulatory compliance standards
- 3.3.2 Environmental concerns
- 3.4. Market Trends
- 3.4.1. Sustainable packaging materials to drive the market growth
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Material Type
- 5.1.1. Plastic
- 5.1.2. Glass
- 5.1.3. Others Materials (Paper and Paperboard And Metal)
- 5.2. Market Analysis, Insights and Forecast - by Product Type
- 5.2.1. Bottles
- 5.2.2. Vials and Ampoules
- 5.2.3. Pouches
- 5.2.4. Syringes
- 5.2.5. Medication Tubes
- 5.2.6. Caps and Closures
- 5.2.7. Labels
- 5.2.8. Others Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Europe
- 5.1. Market Analysis, Insights and Forecast - by Material Type
- 6. Germany Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 7. France Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 8. Italy Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 9. United Kingdom Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 10. Netherlands Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 11. Sweden Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 12. Rest of Europe Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2024
- 13.2. Company Profiles
- 13.2.1 Aptargroup Inc
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 SGD Pharma
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Vetter Pharma Packaging
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Schott AG
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Nolato AB
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Ardagh Group SA
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 Gaplast GmbH
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Nipro Corporation
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Intrapac Group
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.10 Origin Pharma Packaging
- 13.2.10.1. Overview
- 13.2.10.2. Products
- 13.2.10.3. SWOT Analysis
- 13.2.10.4. Recent Developments
- 13.2.10.5. Financials (Based on Availability)
- 13.2.11 CCL Industries Inc
- 13.2.11.1. Overview
- 13.2.11.2. Products
- 13.2.11.3. SWOT Analysis
- 13.2.11.4. Recent Developments
- 13.2.11.5. Financials (Based on Availability)
- 13.2.12 APG Europe
- 13.2.12.1. Overview
- 13.2.12.2. Products
- 13.2.12.3. SWOT Analysis
- 13.2.12.4. Recent Developments
- 13.2.12.5. Financials (Based on Availability)
- 13.2.13 Piramal Glass Ltd*List Not Exhaustive
- 13.2.13.1. Overview
- 13.2.13.2. Products
- 13.2.13.3. SWOT Analysis
- 13.2.13.4. Recent Developments
- 13.2.13.5. Financials (Based on Availability)
- 13.2.14 Gerresheimer AG
- 13.2.14.1. Overview
- 13.2.14.2. Products
- 13.2.14.3. SWOT Analysis
- 13.2.14.4. Recent Developments
- 13.2.14.5. Financials (Based on Availability)
- 13.2.1 Aptargroup Inc
List of Figures
- Figure 1: Europe Pharmaceutical Packaging Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe Pharmaceutical Packaging Industry Share (%) by Company 2024
List of Tables
- Table 1: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Material Type 2019 & 2032
- Table 3: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 4: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Germany Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: France Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Italy Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: United Kingdom Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Netherlands Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Sweden Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Europe Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Material Type 2019 & 2032
- Table 14: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 15: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 16: United Kingdom Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Germany Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: France Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Italy Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Spain Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Netherlands Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Belgium Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Sweden Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Norway Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Poland Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Denmark Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Pharmaceutical Packaging Industry?
The projected CAGR is approximately 7.30%.
2. Which companies are prominent players in the Europe Pharmaceutical Packaging Industry?
Key companies in the market include Aptargroup Inc, SGD Pharma, Vetter Pharma Packaging, Schott AG, Nolato AB, Ardagh Group SA, Gaplast GmbH, Nipro Corporation, Intrapac Group, Origin Pharma Packaging, CCL Industries Inc, APG Europe, Piramal Glass Ltd*List Not Exhaustive, Gerresheimer AG.
3. What are the main segments of the Europe Pharmaceutical Packaging Industry?
The market segments include Material Type, Product Type.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Growth in Pharmaceutical industries in Emerging economies; Growing demand for drug delivery devices & Blister packaging market; Contribution of Nano-technology in the growth of Europe Pharmaceutical packaging; Growth in over-the-counter market; Developing interest in sustainable packaging materials. and integration of smart technologies.
6. What are the notable trends driving market growth?
Sustainable packaging materials to drive the market growth.
7. Are there any restraints impacting market growth?
Increaing Packaging costs; Stricter health regulatory compliance standards. Environmental concerns.
8. Can you provide examples of recent developments in the market?
August 2021 - IntraPac International Corporation announced that it had acquired Precision Concepts Costa Rica, a vertically integrated molder and assembler of medical devices. This partnership helps the compnay to grow larger and manufacture a wider set of products, processes, capabilities.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Pharmaceutical Packaging Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Pharmaceutical Packaging Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Pharmaceutical Packaging Industry?
To stay informed about further developments, trends, and reports in the Europe Pharmaceutical Packaging Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence